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Abstract
Objective: To determine the prevalence and severity of wheezing in infants, using the standardized protocol devised 
for the “Estudio Internacional de Sibilancias en Lactantes” (EISL, International Study of Wheezing in Infants), as 
well as to determine the relationship between such wheezing and physician-diagnosed asthma, in the first year 
of life. Methods: Between March of 2005 and August of 2006, the EISL questionnaire was administered to the 
parents or legal guardians of infants undergoing routine procedures or immunization at public primary health care 
clinics in the southern part of the city of São Paulo, Brazil. Results: Our sample comprised 1,014 infants (mean age 
= 5.0 ± 3.0 months), 467 (46.0%) of whom had at least one wheezing episode, 270 (26.6%) having three or more 
such episodes, in their first year of life. The use of inhaled β2 agonists, inhaled corticosteroids, or antileukotrienes, 
as well as the occurrence of nocturnal symptoms, difficulty breathing, pneumonia, emergency room visits, and 
hospitalization due to severe wheezing, was significantly more common among those with recurrent wheezing 
(p < 0.05). Physician-diagnosed asthma was reported for 35 (7.5%) of the 467 wheezing infants and was found 
to be associated with the use of inhaled corticosteroids, difficulty breathing during the attacks, and six or more 
wheezing episodes in the first year of life. However, less than 40% of those infants were treated with inhaled 
corticosteroids or antileukotrienes. Conclusions: In this study, the prevalence of wheezing episodes among infants 
in their first year of life was high and had an early onset. The proportion of infants diagnosed with and treated 
for asthma was low. 
Keywords: Asthma/diagnosis; Asthma/epidemiology; Respiratory sounds.
Resumo
Objetivo: Avaliar a prevalência e a gravidade da sibilância, bem como sua relação com o diagnóstico médico 
de asma, em lactentes no primeiro ano de vida, utilizando o protocolo padronizado do “Estudio Internacional 
de Sibilancias en Lactantes” (EISL, Estudo Internacional de Sibilâncias em Lactentes). Métodos: Entre março de 
2005 e agosto de 2006, os pais ou responsáveis de lactentes que procuraram unidades básicas de saúde na região 
centro-sul de São Paulo (SP) para procedimentos de rotina e imunização responderam ao questionário escrito do 
EISL. Resultados: A amostra foi constituída por 1.014 lactentes (média de idade = 5,0 ± 3,0 meses), 467 (46,0%) 
dos quais apresentaram sibilância no primeiro ano de vida, sendo que 270 (26,6%) tiveram três ou mais episódios. 
Entre esses últimos, o uso de β2-agonista inalatório, corticosteroide inalatório e antileucotrieno, assim como a 
presença de sintomas noturnos, dificuldade para respirar, pneumonia, idas ao pronto socorro e internação por 
sibilância grave, foram significantemente mais frequentes (p < 0,05). Os pais de 35 (7,5%) dos 467 lactentes 
relataram o diagnóstico médico de asma, o qual foi associado ao uso de corticosteroide inalatório, percepção de 
falta de ar durante as crises e seis ou mais episódios de sibilância no primeiro ano de vida. Entretanto, menos 
de 40% desses lactentes recebiam corticosteroide inalatório ou antileucotrieno como tratamento. Conclusões: A 
prevalência da sibilância no primeiro ano de vida de lactentes no estudo foi alta e teve início precoce. A proporção 
de lactentes diagnosticados e tratados como asmáticos foi baixa. 
Descritores: Asma/diagnóstico; Asma/epidemiologia; Sons respiratórios.
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year of life, among infants living in the southern 
part of the city of São Paulo, Brazil, as well as 
to determine the relationship between such 
wheezing and physician-diagnosed asthma, using 
the standardized protocol devised for the EISL.
Methods
The standardized written questionnaire 
for Phase One of the EISL (WQ-P1-EISL) was 
administered to the parents or legal guardians of 
infants aged 12 to 15 months who lived in the 
southern part of the city of São Paulo, Brazil. 
This region was chosen because it is the region 
in which the International Study of Asthma and 
Allergies in Childhood (ISAAC) Phase One and 
Phase Three were conducted.(6,7)
The infants who had parent-reported chronic 
diseases that could affect the respiratory system 
(neuropathies, myopathies, heart diseases, 
genetic diseases, and severe malformations) 
were excluded from the study, as were those 
for whom the questionnaire was less than 90% 
completed.
From among the 60 primary health care 
clinics in the southern part of the city of São 
Paulo, Brazil, we randomly selected 9, each of 
which is located in a different district of the city. 
The parents or legal guardians who agreed to 
participate in the study gave written informed 
consent and were subsequently interviewed by 
previously trained pediatricians or fifth-year 
medical students of the Universidade Federal de 
São Paulo/Escola Paulista de Medicina (UNIFESP/
EPM, Federal University of São Paulo/Paulista 
School of Medicine). We evaluated infants 
examined during visits to the primary health care 
clinics between 2005 and 2006. These visits were 
for routine procedures, including immunization, 
or were related to one of the four immunization 
campaigns against childhood poliomyelitis run 
during the study period.
The WQ-P1-EISL is an instrument 
composed of 45 questions about demographic 
characteristics, as well as about wheezing and its 
potential risk factors.(5) Originally developed in 
Spanish, it has been translated into Portuguese 
and validated for use in Brazil.(8-10) A question 
developed for the Brazilian population was 
added to this questionnaire: “Has your child 
used oral corticosteroids?”
The data obtained with the WQ-P1-EISL 
were coded in a standard manner, transferred to 
Introduction
Wheezing is one of the most common 
respiratory symptoms in children and can result 
from a number of pulmonary diseases or be 
of other etiologies. Regardless of the cause, 
wheezing is a reason for seeking emergency 
treatment, especially if there are recurrent 
episodes. Recurrent wheezing is a very common 
condition in children, and, in most cases, the 
initial episodes occur in the first year of life.(1)
In infants, there are a number of potential 
causes of recurrent or non-recurrent wheezing, 
such as acute viral bronchiolitis, aspiration 
syndromes, or early-onset asthma. In general, 
infants with recurrent wheezing require special 
medical care, with monitoring from the onset of 
symptoms, as well as appropriate treatment, in 
order to avoid unfavorable outcomes and higher 
morbidity.
As observed in asthma in older children,(2) 
the prevalence and severity rates of recurrent 
wheezing among infants in developing countries 
are likely to be higher than are those found 
among infants in developed countries. Although 
the reasons for such differences remain unknown, 
it is likely that they are attributable to exposure 
to environmental risk factors, especially those 
related to low socioeconomic status.(3,4)
In order to conduct a worldwide comparative 
study of the prevalence of wheezing in infants, 
it is necessary to use a standardized method 
validated for use in the countries (cultures) 
involved in the study. Therefore, it is believed 
that the development of well-standardized 
protocols that are applicable to parents of 
infants will allow the identification of patients 
with recurrent wheezing and, possibly, of those 
with asthma.
The Estudio Internacional de Sibilancias en 
Lactantes (EISL, International Study of Wheezing 
in Infants) was developed to study the impact of 
recurrent wheezing on infants in the first year 
of life, as well as to determine its prevalence 
and associated risk factors.(5) That was an 
international multicenter study involving Latin 
American countries, as well as the Netherlands 
and Spain. In Brazil, eight centers, one of which 
was located in the southern part of the city of 
São Paulo, participated in that study.
The objective of the present study, in its 
first phase, was to determine and describe the 
prevalence and severity of wheezing, in the first 
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EPM and the São Paulo Municipal Department 
of Health.
Results
We interviewed 1,054 parents or legal 
guardians of infants 12-15 months of age. From 
this sample, we excluded 30 questionnaires that 
were completed incorrectly and 10 that were 
related to infants who had heart disease or 
neuropathy. Therefore, the final sample comprised 
1,014 questionnaires. Most respondents were 
mothers (82.1%), followed by fathers (10.8%) 
and other family members (7.1%). Of the 1,054 
infants evaluated, 512 (50.5%) were male. Table 
1 shows the characteristics of the infants who 
had at least one wheezing episode, by gender. 
Among the wheezing infants, the values for 
weight and height (at birth and at 12 months) 
were, as expected, slightly higher for boys than 
for girls, and the difference was statistically 
significant. There were no statistically significant 
differences between the genders in terms of 
ethnicity.
A total of 467 infants (46.0%) were found to 
have had one or more wheezing episodes in the 
first 12 months of life, and the mean age at onset 
was 5.0 ± 3.0 months. Of those, 270 had three 
or more wheezing episodes (recurrent wheezing), 
whereas 100 had six or more wheezing episodes 
(severe recurrent wheezing). Table 2 shows the 
personal and clinical characteristics of each 
group of wheezers.
a database created with Microsoft Excel® 2000, 
and statistically analyzed via the Statistical 
Package for the Social Sciences for Windows, 
version 13.0 (SPSS Inc., Chicago, IL, USA).
The wheezing infants were divided into 
groups by frequency of wheezing episodes: less 
than three wheezing episodes; three or more 
wheezing episodes (recurrent wheezers); and 
six or more wheezing episodes (severe recurrent 
wheezers). Those who had never had a wheezing 
episode were designated non-wheezers.
The infants who had at least one wheezing 
episode were analyzed as to how gender affects 
the frequency of wheezing episodes, the 
symptoms presented, and the use of medications 
for wheezing, as well as the diagnoses of 
asthma, pneumonia, and upper respiratory tract 
infections. The wheezers diagnosed with asthma 
were assessed for severity factors and type of 
treatment given.
Depending on the variables analyzed, 
parametric tests (Student’s t-test) and 
nonparametric tests (chi-square and Fisher’s 
exact test) were used, as was logistic regression. 
Logistic regression was used for the joint 
analysis of the potential severity factors related 
to recurrent wheezing and to a prior diagnosis 
of asthma, in order to determine the factors 
independently related to the outcome. The level 
of significance required in order to reject the 
null hypothesis was set at 0.05.
The present study was approved by the 
Research Ethics Committees of the UNIFESP/
Table 1 - Clinical characteristics of the infants who had had at least one wheezing episode in the first year of 
life by gender.
Characteristic Male Female Overall p*
(n = 259) (n = 208) (n = 467)
n (%) n (%) n (%)
Three or more wheezing episodes 159 (61.4) 111 (53.4) 270 (57.8) 0.1
Six or more wheezing episodes 57 (22.0) 43 (20.7) 100 (21.4) 0.8
Use of inhaled β2-agonists 218 (84.2) 184 (88.5) 402 (86.1) 0.2
Use of inhaled corticosteroids 37 (14.3)** 17 (8.2) 54 (11.5) 0.04
Use of antileukotrienes 10 (3.9) 2 (0.9) 12 (2.5) 0.09
Use of oral corticosteroids 123 (47.5) 86 (41.3) 209 (44.7) 0.2
Nocturnal awakenings sometimes 166 (64.1) 124 (59.6) 290 (62.0) 0.4
Emergency room visits 169 (65.2) 129 (62.0) 298 (63.8) 0.5
Difficulty breathing as perceived by parents 132 (50.1) 95 (45.7) 227 (48.6) 0.3
Hospitalization due to bronchitis 53 (20.5) 39 (18.8) 92 (19.6) 0.7
Physician-diagnosed asthma 24 (9.3) 11 (5.3) 35 (7.4) 0.1
Pneumonia 92 (35.5)** 52 (25.0) 144 (30.8) 0.02
Hospitalization due to pneumonia 43 (16.6) 28 (13.5) 71 (15.2) 0.4
*Fisher’s exact test or chi-square test. **Statistically significant.
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question about the use of oral corticosteroids, 
and, of those, 209 (48.7%) reported having 
used oral corticosteroids to treat wheezing. 
The analysis of the relationship of the use of 
oral corticosteroids as an associated factor 
with higher frequency and greater severity 
of wheezing episodes revealed no significant 
association between the variables.
Discussion
In Brazil, the city of São Paulo is one of the 
areas with the highest prevalence of wheezing 
and asthma among children and adolescents.
(11,12) However, there have been only a few studies 
evaluating the prevalence of wheezing in infants 
in the metropolitan area of São Paulo, the largest 
urban area in South America. The situation is 
not different in other large urban areas in Brazil, 
nor is it different in other developing countries.
More than one decade ago, the prevalence 
of recent wheezing (one or more episodes in 
the last 12 months) among children aged 12 to 
23 months and living in the city of São Paulo was 
estimated to be 14.3%.(13) A birth cohort study 
involving individuals at high risk of developing 
asthma (parents with atopy), conducted on 
the outskirts of the southern part of the city, 
documented that, at 30 months, 52% of the 
participating children had recurrent wheezing.(3) 
In the present study, we found a high prevalence 
Multivariate analysis revealed that recurrent 
wheezing was independently associated with the 
use of inhaled corticosteroids (OR = 2.2; 95% CI: 
1.1-4.4; p = 0.03), frequent nocturnal symptoms 
(OR = 3.5; 95% CI: 2.3-5.2; p < 0.001), emergency 
room visits (OR = 1.6; 95% CI: 1.1-2.5; p = 0.02), 
and physician-diagnosed pneumonia (OR = 3.5; 
95% CI: 1.8-6.6; p = 0.005). Severe recurrent 
wheezing was independently associated with 
frequent nocturnal symptoms (OR = 2.9; 95% 
CI: 1.6-5.2; p < 0.001), difficulty breathing as 
perceived by parents (OR = 1.8; 95% CI: 1.1-2.9; 
p = 0.03), hospitalization due to wheezing (OR = 
1.9; 95% CI: 1.1-3.3; p = 0.03), and physician-
diagnosed pneumonia (OR = 1.8; 95% CI: 
1.1-3.1; p = 0.02).
Physician-diagnosed asthma was reported 
for 35 (7.5%) of the 467 wheezing infants. 
Table 3 shows the comparison of the clinical 
characteristics of the infants with and without 
physician-diagnosed asthma. The multivariate 
analysis revealed that physician-diagnosed 
asthma was independently associated with 
the use of inhaled corticosteroids (OR = 2.97; 
95% CI: 1.32-6.69; p = 0.009), difficulty 
breathing during the attacks (OR = 4.42; 95% 
CI: 1.30-14.5; p = 0.02), and having had six 
or more wheezing episodes (OR = 2.15; 95% 
CI: 1.02-4.52; p = 0.04).
Of the parents or legal guardians of the 
wheezing infants, 429 (91.9%) responded to the 
Table 2 - Personal and clinical characteristics of the infants by number of wheezing episodes in the first year 
of life (n = 467).
Variable Episodes/year
< 3 ≥ 3 p* < 6 ≥ 6 p*
(n = 197) (n = 270) (n = 367) (n = 100)
Male gender, n (%) 100 (21.4) 159 (34.0) 0.08 202 (43.3) 57 (12.2) 0.8
Weight at birth, kga 3.2 ± 0.6 3.1 ± 0.6 0.06 3.2 ± 0.6** 3.0 ± 0.6 0.01
Current weight, kga 10.1 ± 1.5 10.3 ± 1.4 0.2 10.2 ± 1.5 10.5 ± 1.4** 0.03
Height at birth, cma 48.0 ± 3.4 47.9 ± 3.2 0.4 48.0 ± 3.4 47.9 ± 3.1 0.6
Current height, cma 75.3 ± 5.9 74.9 ± 4.3 0.6 75.1 ± 5.3 75.1± 3.6 0.9
Age at wheezing onset, monthsa 6.2 ± 3.4** 4.1 ± 2.5 < 0.001 5.5 ± 3.1** 3.3 ± 2.3 < 0.001
Black/Mulatto, n (%) 68 (14.6) 87 (18.6) 0.7 124 (26.5) 31 (6.6) 0.6
Use of inhaled β2-agonists, n (%) 162 (82.2) 240 (88.9)** 0.04 310 (84.5) 92 (92.0)** 0.07
Use of inhaled corticosteroids, n (%) 13 (6.6) 41 (15.2)** 0.007 36 (9.8) 18 (18.0)** 0.04
Use of antileukotrienes, n (%) 4 (2.0) 8 (2.9) 0.7 9 (2.5) 3 (3.0) 0.7
Use of oral corticosteroids, n (%) 81 (41.1) 127 (47.0) 0.2 47 (12.8) 48 (48.0) 0.9
Occasional nocturnal awakenings, n (%) 88 (44.7) 202 (74.8)** < 0.001 207 (56.4) 83 (83.0)** < 0.001
Emergency room visits, n (%) 105 (53.3) 193 (71.5)** < 0.001 218 (59.4) 80 (80.0)** < 0.001
Difficulty breathing as perceived by parents, n (%) 83 (42.1) 144 (53.3)** 0.02 159 (43.3) 68 (68.0)** < 0.001
Hospitalization due to wheezing, n (%) 30 (15.2) 62 (23.0)** 0.04 55 (11.8) 37 (37.0)** < 0.001
Physician-diagnosed asthma, n (%) 7 (3.5) 28 (10.4)** 0.007 20 (5.4) 15 (15.0)** 0.002
Pneumonia, n (%) 40 (20.3) 104 (38.5)** < 0.001 94 (25.6) 50 (50.0)** < 0.001
Hospitalization due to pneumonia, n (%) 25 (12.7) 46 (17.0) 0.2 43 (11.7) 28 (28.0)** < 0.001
aResults expressed as mean ± SD (Student’s t-test). *Chi-square test or Fisher’s exact test. **Statistically significant.
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factors and to the poor socioeconomic status of 
the populations in those areas. In studies using 
the same instrument and method to evaluate 
infants in the same age group, the prevalence 
rates in the city of Curitiba, Brazil, were found 
to similar for wheezing (45.4%) and recurrent 
wheezing (22.6%),(16) whereas the prevalence 
rates in the Netherlands were found to be lower 
for wheezing (28.5%) and recurrent wheezing 
(14.5%).(17)
In the present study, having been diagnosed 
with pneumonia and having been hospitalized due 
to pneumonia were found to be independently 
associated with recurrent wheezing and 
severe recurrent wheezing. It is likely that the 
number of infants diagnosed with pneumonia 
was overestimated in our sample, because the 
limitations, difficulties, and contradictions in 
the diagnosis of acute infectious pulmonary 
diseases in children are extremely common in 
clinical practice.(18) However, the high percentage 
of infants who had respiratory infection with 
pulmonary impairment in this sample is still a 
cause of concern. According to the Brazilian 
National Ministry of Health, respiratory diseases 
were responsible for 34.5% of all hospital 
admissions of children less than one year of age 
nationwide in 2006. In the city of São Paulo, 
this rate was 34.9%.(19) The association between 
wheezing and pneumonia is well known(20) 
and clearly points to recurrent wheezing as a 
serious public health problem. However, in Brazil 
and in other developing countries, although 
of wheezing in a representative sample of the 
population in the southern part of the city, and 
slightly less than half of the infants had had at 
least one wheezing episode in the first year of 
life. The variation observed between previous 
studies and the present study might be related 
to the lack of standardization of the methods 
used to identify infants, to the type of study 
conducted, to the definition of wheezing, and 
to the age group studied.
Among the wheezers, there was a 
predominance of male infants, who also had a 
higher frequency of pneumonia episodes and 
received inhaled corticosteroids for the treatment 
of wheezing more frequently than did female 
infants (Table 1). Studies have demonstrated 
that male gender is a risk factor for wheezing 
in children, and it has been suggested that the 
smaller airway diameter in boys at birth is an 
explanation for this.(1)
Nearly 1 in every 4 infants evaluated had 
recurrent wheezing, which was defined as the 
report of three or more wheezing episodes in 
the first year of life. The infants in this group 
had earlier onset of episodes (Table 2), received 
inhaled corticosteroids more frequently, and 
more often showed signs of greater severity 
than did those in the group with non-recurrent 
wheezing (multivariate analysis). Isolated studies 
have suggested that the prevalence and severity 
of recurrent wheezing are higher in developing 
countries than in developed countries.(4,14,15) It 
is likely that this is related to environmental 
Table 3 - Personal and clinical characteristics of the infants with and without physician-diagnosed asthma.
Characteristic With asthma Without asthma p*
(n = 35) (n = 432)
n (%) n (%)
Male gender 24 (68.6) 235 (54.4) 0.1
Use of inhaled β2-agonists 35 (100.0)** 367 (85.0) 0.008
Use of inhaled corticosteroids 11 (31.4)** 43 (10.0) < 0.001
Use of antileukotrienes 3 (8.6) 9 (2.1) 0.06
Use of oral corticosteroids 22 (62.9)** 187 (43.3) 0.03
Pneumonia 17 (48.6)** 127 (29.4) 0.02
Hospitalization due to pneumonia 11 (31.4)** 60 (13.9) 0.01
Six or more wheezing episodes 15 (42.9)** 85 (19.7) 0.004
Three or more wheezing episodes 28 (80.0)** 242 (56.0) 0.007
Nocturnal symptoms 29 (82.9)** 261 (60.4) 0.01
Emergency room visits 32 (91.4)** 266 (61.6) < 0.001
Difficulty breathing as perceived by parents 26 (74.3)** 201 (46.5) 0.002
Hospitalization due to wheezing 16 (45.7)** 76 (17.6) < 0.001
*Fisher’s exact test. **Statistically significant.
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demonstrated that the use of the overall ISAAC 
score(12) and the enquiry regarding the occurrence 
of wheezing episodes in the last 12 months was 
more reliable than was the enquiry regarding 
physician-diagnosed asthma or bronchitis.(24)
In the present study, the infants diagnosed 
with asthma had more wheezing attacks and 
more often showed signs of severity than did 
the other wheezing infants, pneumonia and 
hospitalizations being more common among the 
former (Table 3). Logistic regression revealed that 
physician-diagnosed asthma was significantly 
associated with a larger number of wheezing 
attacks, difficulty breathing as perceived by 
parents, and the use of inhaled corticosteroids. 
This indicates that physician-diagnosed asthma 
is likely to be limited to the more severe 
presentations of wheezing. Nevertheless, 
although there was a formal prescription for 
inhaled corticosteroids or antileukotrienes, less 
than 40% of the children with asthma received 
the recommended treatment. The treatment of 
asthma in children is characterized by its greater 
complexity, which results from the difficulties 
in adapting the inhalation techniques, from 
the different patient phenotypes, and from 
the potentially more serious risks from the side 
effects of the medications.(22) These factors are 
likely to have negatively affected the percentage 
of wheezing infants receiving specific treatment 
in the present study.
In contrast, practically half of the wheezing 
infants received oral corticosteroids as rescue 
medication during the attacks. In accordance 
with the guidelines for the treatment of wheezing 
in children,(22) the use of oral corticosteroids is 
recommended for more severe wheezing attacks. 
However, this association was not observed in 
the present study. It is likely that this medication 
was prescribed for the treatment of milder cases, 
or even for the treatment of other diseases, such 
as viral bronchiolitis, which represents a potential 
information bias for the severity of wheezing in 
this population. In addition, the fact that the 
prescription of oral corticosteroids has become 
commonplace causes concern regarding their 
potential side effects, which are not always 
borne in mind. In the literature on the treatment 
of wheezing in infants and small children, there 
is no scientific basis for this approach. Recently, 
a study compared the use of oral prednisolone 
with that of placebo in preschool children with 
the morbidity and mortality associated with 
respiratory infections are high in the first year 
of life,(21) the true prevalence of wheezing in this 
age group was unknown at the time.
We found the occurrence of nocturnal 
symptoms, emergency room visits, difficulty 
breathing as perceived by parents, and wheezing 
to be quite common in all groups of wheezers, 
a higher frequency of episodes translating, as 
expected, to a statistically significant percentage 
increase (Table 2). The infants with severe 
recurrent wheezing had the first attack early, 
at 3 months on average (Table 2). Although 
severe recurrent wheezing was independently 
associated with signs of severity, such as difficulty 
breathing during the attacks and hospitalization 
due to wheezing, only 18.0% and 3.0% of 
the infants received inhaled corticosteroids 
or antileukotrienes, respectively, as a specific 
treatment (Table 2). This is likely due to the 
low percentage of wheezers identified as having 
asthma.
Diagnosing asthma in the first year of life 
is known to be difficult, since many diseases 
can manifest as recurrent episodes of cough or 
wheezing, or both, in this period.(22) However, 
asthma is the most prevalent chronic respiratory 
disease in children,(22) and the intensity of the 
symptoms in the first two years of life is strongly 
associated with late prognosis.(23) One prospective 
study found that most of the children with 
wheezing had had the first episodes in the first 
year of life. Of those, half continued to have 
wheezing episodes until 6 years of age, being 
classified as having asthma,(1) which indicates 
the need for improvements in the diagnosis and 
early treatment of asthma and wheezing.
In Brazil, and especially in the state of 
São Paulo, the term “bronchitis” is frequently 
employed when referring to asthma in 
children, which produces an additional bias in 
epidemiological assessments.(24) This might have 
contributed to the underdiagnosis of asthma 
in the present study. However, it is of interest 
that the diagnosis of asthma also was much less 
common than was the occurrence of wheezing 
episodes in the last 12 months among older 
children (aged 6 and 7 years) and adolescents 
(aged 13 and 14 years) who participated in 
the ISAAC in Brazil.(25) Recently, one group of 
authors, who evaluated different criteria for the 
diagnosis of asthma in children and adolescents, 
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and symptom perception, with good levels of 
accuracy.(30)
We conclude that, among infants in the 
southern part of the city of São Paulo, Brazil, 
the prevalence of wheezing in the first year of 
life is high, wheezing has an early onset and high 
morbidity, with approximately 27% of the infants 
having recurrent episodes with higher morbidity 
and greater severity, and the high prevalence of 
wheezing increases the incidence of pneumonia, 
requiring that such infants receive specialized 
care. Infants with physician-diagnosed asthma 
more often experienced episodes of wheezing, 
and those episodes were more severe than were 
those experiences by infants without physician-
diagnosed asthma. However, less than half of 
the infants with physician-diagnosed asthma 
received specific asthma treatment. The high 
prevalence of wheezing, combined with low rates 
of physician-diagnosed asthma and the adoption 
of a therapeutic approach different from the 
one recommended for such cases, indicates the 
magnitude of the problem of asthma in children 
and underscores the need for public health 
measures targeting this population.
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